Impact of continuous glucose monitoring on pregnancy outcomes in women with pregestational diabetes
- PMID: 39760786
- DOI: 10.1007/s00592-024-02439-2
Impact of continuous glucose monitoring on pregnancy outcomes in women with pregestational diabetes
Abstract
Aims: This study aims to evaluate the impact of continuous glucose monitoring (CGM) on pregnancy outcomes in women with pregestational diabetes mellitus (PGDM).
Methods: A retrospective cohort study was conducted on 387 pregnant women with PGDM at Virgen del Rocío University Hospital in Seville, spanning from 2016 to 2022. The patients were categorized into two groups: 212 women who used continuous glucose monitoring (CGM) and 175 women who self-monitoring of blood glucose (SMBG). The study evaluated maternal characteristics, pregnancy complications, delivery methods, neonatal outcomes, and congenital anomalies.
Results: The CGM group exhibited lower weight gain during pregnancy (9.6 kg vs. 10.0 kg, p = 0.02) and required fewer prenatal visits (7 vs. 8, p = 0.01). The rate of cesarean sections was significantly lower in the CGM group (53.1% vs. 58.2%, p = 0.03), and the incidence of macrosomia was reduced (12.9% vs. 22.2%, p = 0.04). There were no significant differences in congenital anomalies, intrauterine fetal deaths, or neonatal deaths between the groups.
Conclusions: CGM in pregnant women with PGDM is associated with better pregnancy outcomes, including reduced cesarean section rates and lower incidence of macrosomia. These findings support the wider implementation of CGM for improved maternal and fetal health in PGDM pregnancies.
Keywords: Cesarean section; Continuous glucose monitoring; Glycemic control; Macrosomia; Obstetric management; Pregestational diabetes mellitus; Pregnancy outcomes.
© 2025. Springer-Verlag Italia S.r.l., part of Springer Nature.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: nstitutional Review Board approval of this study was obtained from the Andalusian Ethical Committee (Spain) on 21 November 2021 (ref. 1657-N-21). The requirement for informed consent was officially waived because the data were de-identified, and due to the anonymous nature of the data collection process. The research protocol was submitted to the Andalusian Ethical Committee before starting the collection of data. The study was conducted in accordance with the Declaration of Helsinki and other nationally valid relevant guidelines and regulations. Competing interest: The authors declare that there are no competing interests regarding the publication of this paper.
Similar articles
-
Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.Cochrane Database Syst Rev. 2017 Jun 11;6(6):CD009613. doi: 10.1002/14651858.CD009613.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2019 May 23;5:CD009613. doi: 10.1002/14651858.CD009613.pub4. PMID: 28602020 Free PMC article. Updated.
-
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.Eur J Endocrinol. 2025 Jun 30;193(1):G1-G48. doi: 10.1093/ejendo/lvaf116. Eur J Endocrinol. 2025. PMID: 40652450
-
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.J Clin Endocrinol Metab. 2025 Aug 7;110(9):2405-2452. doi: 10.1210/clinem/dgaf288. J Clin Endocrinol Metab. 2025. PMID: 40652453 Free PMC article.
-
Discrete glucose profiles identified using continuous glucose monitoring data and their association with adverse pregnancy outcomes.Am J Obstet Gynecol. 2024 Jul;231(1):122.e1-122.e9. doi: 10.1016/j.ajog.2024.03.026. Epub 2024 Mar 23. Am J Obstet Gynecol. 2024. PMID: 38527606 Free PMC article.
-
Continuous glucose monitoring systems for type 1 diabetes mellitus.Cochrane Database Syst Rev. 2012 Jan 18;1(1):CD008101. doi: 10.1002/14651858.CD008101.pub2. Cochrane Database Syst Rev. 2012. PMID: 22258980 Free PMC article.
References
-
- Wahabi HA, Alzeidan RA, Esmaeil SA (2012) Pre-pregnancy care for women with pre-gestational diabetes mellitus: a systematic review and meta-analysis. BMC Public Health 12(1):792. https://doi.org/10.1186/1471-2458-12-792 - DOI - PubMed - PMC
-
- Murphy HR, Roland JM, Skinner TC, Simmons D, Gurnell E, Morrish NJ et al (2010) Effectiveness of a Regional Prepregnancy Care Program in Women with Type 1 and type 2 diabetes. Diabetes Care 33(12):2514–2520. https://doi.org/10.2337/dc10-1113 - DOI - PubMed - PMC
-
- Kautzky-Willer A, Harreiter J, Winhofer-Stöckl Y, Weitgasser R, Lechleitner M (2019) Gravidität Bei Vorbestehendem Diabetes (Update 2019). Wien Klin Wochenschr 131(S1):103–109. https://doi.org/10.1007/s00508-023-02188-2 - DOI - PubMed
-
- Kitzmiller JL, Block JM, Brown FM, Catalano PM, Conway DL, Coustan DR et al (2008) Managing Preexisting diabetes for pregnancy. Diabetes Care 31(5):1060–1079. https://doi.org/10.2337/dc08-9020 - DOI - PubMed
-
- Feig DS, Hwee J, Shah BR, Booth GL, Bierman AS, Lipscombe LL (2014) Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: a large, Population-based study in Ontario, Canada, 1996–2010. Diabetes Care 37(6):1590–1596. https://doi.org/10.2337/dc13-2717 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical